Cite
HARVARD Citation
Jodele, S. et al. (2018). High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma. Bone marrow transplantation. pp. 1311-1318. [Online].